If this box remains here for more than 30 seconds, click this link to try again.
Products & Services »
Best Practice Database
New Product Development » New Product Planning
Download FREE Excerpt
18 Info Graphics
15 Data Graphics
Single User: Authorizes use by the person who places the order or for whom the order was placed.
Sitewide: Authorizes use of the report for a geographic site. All people at site can view the report for a year and copies can be printed.
Corporate: Authorizes use for the entire company for a year and copies can be printed. No limitations for usage inside the company.
The New Product Planning (NPP) function within the pharmaceutical industry has the challenging task of guiding potential new products through the complicated and costly development process. One of the principal tasks for the NPP team is to oversee key activities that will provide a picture of a new therapy's market potential. It's these activities that executives use to decide whether to continue a new product's development.
Best Practices, LLC undertook this benchmarking study to provide a road map for the timing of key market planning activities for the NPP group. In particular, this study shows when NPP teams - both global and regional - are involved in activities such as draft launch label, competitive assessment, market assessment, target product profile and others. There is also a chapter that provides an overview of the current state of new product planning.
For this research project, Best Practices, LLC engaged 19 leaders from 15 leading pharmaceutical, biotech, and life sciences companies.
Biopharmaceutical; Pharmaceutical; Medical Device; Biotech; Health Care; Clinical Research; Laboratories; Manufacturing; Consumer Products; Diagnostic
Alkermes; Zydus Cadila; GlaxoSmithKline ; Astellas; Roche; Novartis; Sanofi; Pfizer; Takeda Pharmaceuticals; Cytokinetics; Allergan; Medicago; Bayer; Galderma; Wockhardt